Technical Description
This technology is a hydrogel composite scaffold designed for bone tissue engineering, incorporating cobalt ferric oxide (CFO)-loaded halloysite nanotubes within a nano hydroxyapatite and sodium alginate matrix. The formulation delivers targeted stem cell recruitment, controlled bio-active release, and synchronized structural degradation to drive bone tissue repair and regeneration.
Problems Addressed
- Unsynchronized Scaffold Degradation
- Insufficient Osteoinductive Recruitment
- Mechanical Strength Mismatch
- Inadequate Cell Integration
- Poor Multi-Material Synergy
Tech Features
- CFO-Loaded Halloysite Nanotubes
- Nano-Hydroxyapatite Hydrogel Matrix
- Controlled Active Release
- Stem Cell Recruitment
- Cross-Linked Structural Mesh
- Synchronized Degradation Kinetics
Target Audience
- Regenerative medicine industries
- Biomedical device manufacturers
- Orthopedic surgery sectors
- Biomaterials manufacturing industries
- Advanced clinical Therapeutics
Tech ID: P22-2222 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
